Conformis Announces Achievement of Third Milestone Under Development and License Agreements
April 22, 2021 16:30 ET
|
Conformis, Inc.
BILLERICA, Mass., April 22, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it received 510(k) clearance by the U.S. Food and Drug Administration for patient-specific...
Conformis Announces Achievement of Second Milestone Under Development and License Agreements
August 20, 2020 07:30 ET
|
Conformis, Inc.
BILLERICA, Mass., Aug. 20, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it completed the second of three milestones pursuant to the License Agreement and Development...